European Archives - Page 498 of 900 - European Medical Journal

Continue
August 2019

EMJ Dermatology 7 [Suppl 4] 2019

The main objectives of the symposium were to define the need for ambitious goals in the treatment of psoriasis, including the importance of clear skin…
10 Mins
20th August 2019

Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference

Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
16th August 2019

ESHRE 2019 – Interview – Prof Michael Grynberg

An interview with Prof Michael Grynberg, Head, Department of Reproductive Medicine & Fertility Preservation, Hôpital Antoine Béclère, at this year’s ESHRE…
14th August 2019

An interview with Daniel Carucci, McCann Health

We recently met with Daniel Carucci, Global Medical Director, McCann Health, at the 2019 Cannes Lions Festival of Creativity. Daniel discusses…
1 Mins
13th August 2019

Vaccination use Increases Gout Flare Risk

Gout is caused by sodium urate crystals formation in joints, resulting in sudden and severe joint pain. Research had shown that the inflammatory response…
1 Mins
13th August 2019

Reduced Coronary Inflammation via Psoriasis Therapy

Associated with heightened systemic inflammation, which elevates the risk of blood vessel disease and diabetes, psoriasis a chronic autoimmune disease…
August 2019

EMJ Neurology 7.1 2019

This year, the European Academy of Neurology (EAN) annual meeting was held in the cultural and captivating city of Oslo, Norway. There was a huge…
1 Mins
13th August 2019

The European Medical Journal Presents: EMJ Neurology 2019

The newest edition of EMJ Neurology is published today, featuring an independent review of this year’s EAN Congress including abstract reviews…
10 Mins
13th August 2019

Review of the European Academy of Neurology Congress 2019

Attracting over 6,000 neurologists from countries worldwide, the European Academy of Neurology (EAN) 2019 Congress was a hive for the sharing of…
7 Mins
13th August 2019

Optimism and Opportunities with Anti-CGRP Biologics in Migraine: Where Are We Today?

Migraine is a complex neurological disorder with an approximate global prevalence of 15%. It is characterised by a moderate-to-severe unilateral…